{"title":"Scientific program","authors":"","doi":"10.1111/bcpt.14065","DOIUrl":null,"url":null,"abstract":"<p><b>WEDNESDAY 16 OCTOBER 2024</b></p><p>10:00–14:00<b> ANNUAL MEETING OF RESEARCH ETHICS COMMITTEES</b></p><p>Spanish Agency of Medicines and Medical Devices and Spanish Society of Clinical Pharmacology</p><p>15:30–18:30<b> PRE-CONGRESS WORKSHOPS AND SEMINARS</b></p><p><b>“Next-generation of “deep” medicine: A look from machine learning to generative AI”</b></p><p>Guillermo Prada Ramallal. <i>Clinical Pharmacologist, Hospital Clínico Universitario, Santiago de Compostela</i>.</p><p>Laura Romero Sánchez. <i>Technical Secretary of Research Ethics Committee of Galicia</i>, <i>Gerencia del Servicio Gallego de Salud</i>.</p><p><b>“Drafting and requesting competitive projects”</b></p><p>Joaquín Sáez Peñataro. <i>Clinical Pharmacologist, Hospital Clínic, Barcelona</i>.</p><p>Paula López Vázquez. <i>Clinical Pharmacologist, Dirección Xeral de Asistencia Sanitaria-Servizo Galego de Saúde</i>.</p><p><b>“Professional opportunities for the specialty of clinical pharmacology”</b></p><p>Joaquín Sáez Peñataro. <i>Clinical Pharmacologist, Hospital Clínic, Barcelona</i>.</p><p><b>“Evaluation of the therapeutic value of medicines: controversies and future perspectives”</b></p><p>Arantxa Sancho López. <i>Clinical Pharmacologist, Head of Medical-Scientific Department of Farmaindustria</i>.</p><p>Emilio Vargas Castrillón. <i>Professor of Pharmacology, Head of Clinical Pharmacology Department, Hospital Clínico San Carlos, Universidad Complutense, Madrid</i>.</p><p>Pedro Zapater Hernández<i>. Head of Section of Clinical Pharmacology Department, Hospital General Universitario Dr. Balmis, Universidad Miguel Hernández, Alicante</i>.</p><p>Alejandro García Solís. <i>Therapeutic Positioning Reporting Area and Health Technology Assessment, Spanish Agency of Medicines and Medical Devices</i>.</p><p><b>“Medicines in special situations”</b></p><p>Concepción Payares Herrera. <i>Clinical Pharmacologist, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid</i>.</p><p>Imma Danés Carreras. <i>Head of section of Clinical Pharmacology Department, Hospital Universitario Vall d'Hebron, Barcelona</i>.</p><p>19:00 <b>INAUGURATION OF THE CONGRESS</b></p><p>Antònia Agustí Escasany. <i>President of the Spanish Society of Clinical Pharmacology</i>.</p><p>Emilio Vargas Castrillón. <i>President of the Organizing Committee of the XXXII Congress of the Spanish Society of Clinical Pharmacology</i>.</p><p>Guillermo Prada Ramallal<i>. President of the Scientific Committee of the XXXII Congress of the Spanish Society of Clinical Pharmacology</i>.</p><p>Carmen Durán. <i>General Director of Public Health, Consejería de Sanidad Gobierno Gallego</i>.</p><p>19:30<b> INAUGURAL CONFERENCE</b></p><p><b>“Novelties in therapeutics: Advanced therapies and other innovations”</b></p><p>Cristina Avendaño Solá. Head of Clinical Pharmacology Department, Hospital Puerta de Hierro, Majadahonda, Universidad Autónoma, Madrid.</p><p>20:30<b> WELCOME COCKTAIL</b></p><p><b>THURSDAY 17 OCTOBER 2024</b></p><p>08:30–09:15<b> REGISTRATION</b></p><p>09:15–11:15 <b>1ST ROUND TABLE</b></p><p><b>“Medicine research in Europe, pros and cons of making the medicine authorization process more flexible”</b></p><p>Moderators:</p><p>Ana Lucía Arellano Andrino. <i>Clinical Pharmacologist, Hospital Clínic, Barcelona</i>.</p><p>Emilio Vargas Castrillón. <i>Professor of Pharmacology, Head of Clinical Pharmacology Department, Hospital Clínico San Carlos, Universidad Complutense, Madrid</i>.</p><p>09:20–09:40 <b>“Evolution of medicine authorization procedures in Europe”</b></p><p>Macarena Rodríguez Mendizábal. <i>Division of Clinical Pharmacology and Assessment of Medicines, Spanish Agency of Medicines and Clinical Devices</i>.</p><p>09:40–10:00 <b>“Impact of accelerating medicine authorization processes on healthcare management”</b></p><p>Antoni Vallano Ferraz. <i>Coordinator of the Drug Harmonization Program, Àrea del Medicament del Servei Català de la Salut</i>.</p><p>10:00–10:20 <b>“The research on medicines in Europe, pros and cons of making the drug authorization more flexible. Advantages and uncertainties in the paediatric population”</b></p><p>Federico Martinón Torres. <i>Head of Paediatric Department, Hospital Clínico Universitario, Santiago de Compostela</i>.</p><p>10:20–10:40 <b>“The research on medicines in Europe, pros and cons of making the drug authorization more flexible. Advantages and uncertainties in the oncological patients”</b></p><p>Luis León Mateos. <i>Head of Section of Research and Innovation, Clinical Oncology Department, Hospital Clínico Universitario, Santiago de Compostela</i>.</p><p>10:40–11:15 <b>DISCUSSION</b></p><p>11:15–12:00 <b>COFFEE BREAK, POSTER SESSION AND NETWORKING</b></p><p>12:00–13:30 <b>1ST SESSION OF ORAL COMMUNICATIONS</b></p><p>Moderators:</p><p>Encarnación Blanco Reina. <i>Clinical Pharmacologist, Department of Pharmacology and Paediatrics, Universidad de Málaga</i>.</p><p>Pedro Zapater Hernández. <i>Head of Section Clinical Pharmacology Department, Hospital General Universitario Dr Balmis, Universidad Miguel Hernández, Alicante</i>.</p><p>13:30–14:00 <b>“Strategy for the implementation of pharmacogenetics at the healthcare level in the Community of Madrid”</b></p><p>Susana Almenara Riquer. <i>Clinical Pharmacology Department, Hospital Universitario de la Princesa, Madrid</i>.</p><p>Elena Diago Sempere. <i>Clinical Pharmacology Department, Hospital Universitario La Paz, Madrid</i>.</p><p>Gustavo Centeno Soto. <i>Clinical Pharmacology Department, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid</i>.</p><p>Ana Ascaso del Río. <i>Clinical Pharmacology Department, Hospital Universitario Clínico San Carlos, Madrid</i>.</p><p>Antonio Carcas Sansúan<i>. Hospital Universitario La Paz, Madrid</i>.</p><p>Alberto Borobia Pérez<i>. Hospital Universitario La Paz, Madrid</i>.</p><p>Cristina Avendaño Sola. <i>Hospital Universitario Puerta de Hierro, Majadahonda, Madrid</i>.</p><p>Francisco Abad Santos. <i>Hospital Universitario de la Princesa, Madrid</i>.</p><p>14:00–15:30 <b>LUNCH</b></p><p>15:30–17:00 <b>2ND ROUND TABLE</b></p><p><b>“Chronic diseases, polytherapy and health outcomes”</b></p><p>Moderators:</p><p>Mª Estrella Barceló Colomer. <i>Clinical Pharmacologist, Medicine Area of Primary Care Management and Community Care in Barcelona City, Institut Català de la Salut</i>.</p><p>Mario González Ruíz. <i>Clinical Pharmacologist, Clinical Pharmacology Department of Primary Care, Gerencia de Atención Primaria del Servicio Cántabro de Salud</i>.</p><p>15:35–15:55 <b>“The epidemiology of chronicity and polypharmacy”</b></p><p>Arturo González Quintela. <i>Specialist in Internal Medicine, Head of Section Internal Medicine Department, Hospital Clínico Universitario, Santiago de Compostela</i>.</p><p>15:55–16:15 <b>“Polypharmacy and deprescription”</b></p><p>Beatriz Montero Errasquín. <i>Specialist in Geriatrics, Head of Section Geriatric Department, Hospital Universitario Ramón y Cajal, Servicio Madrileño de Salud</i>.</p><p>16:15–16:35 <b>“Health outcomes in chronic patients with polytherapy”</b></p><p>Rosendo Bugarín González. <i>Family Doctor, Monforte de Lemos Health Center, Servicio Galego de Saúde</i>.</p><p>16:35–17:00 <b>DISCUSSION</b></p><p>17:00–17:30 <b>COFFEE BREAK, POSTER SESSION AND NETWORKING</b></p><p>17:30–19:30 <b>GENERAL ASSEMBLY OF THE SPANISH SOCIETY OF CLINICAL PHARMACOLOGY</b></p><p>21:00 <b>CONGRESS DINNER</b></p><p><b>FRIDAY 18 OCTOBER 2024</b></p><p>09:00–10:30 <b>2ND SESSION OF ORAL COMMUNICATIONS</b></p><p>Moderators:</p><p>María del Mar García Saiz. <i>Head of Clinical Pharmacology Department, Hospital Universitario Marqués de Valdecilla, Santander</i>.</p><p>Amelia García Luque. <i>Head of Clinical Pharmacology Department, Hospital Central de la Defensa, Madrid</i>.</p><p>10:30–11:00 <b>COFFEE BREAK, POSTER SESSION AND NETWORKING</b></p><p>11:00–13:00 <b>3RD ROUND TABLE</b></p><p><b>“Artificial intelligence in Medicine: technology, research, education and ethics”</b></p><p>Moderators:</p><p>Emilio Vargas Castrillón. <i>Professor of Pharmacology, Head of Clinical Pharmacology Department, Hospital Clínico San Carlos, Universidad Complutense, Madrid</i>.</p><p>Guillermo Prada Ramallal. <i>Clinical Pharmacologist, Hospital Clínico Universitario, Santiago de Compostela</i>.</p><p>11:05–11:25 <b>“Generative AI in Medicine”</b></p><p>Senén Barro Ameneiro. <i>Director of the USC-Plexus of AI in personalized precision medicine and director of the unique research center in intelligent technologies, Universidad de Santiago de Compostela</i>.</p><p>11:25–11:45 <b>“Use of artificial intelligence in pharmacoepidemiological research: Experience and application perspectives in BIFAP”</b></p><p>Miguel Ángel Maciá Martínez. <i>Coordinator of the Pharmacoepidemiologic Research in Public Health Systems Database, Head of the Pharmacoepidemiology Area, Pharmacoepidemiology and Pharmacovigilance Division, Spanish Agency of Medicines and Medical Devices</i>.</p><p>11:45–12:05 <b>“Challenges for the widespread implementation of AI in healthcare”</b></p><p>Maria José Carreira Nouche. <i>Unique Research Center in Intelligent Technologies, Universidad de Santiago de Compostela, Fundación Instituto de Investigación Sanitaria de Santiago de Compostela</i>.</p><p>12:05–12:25 <b>“Reliable AI in Medicine: Regulation and Ethics”</b></p><p>Juan Díaz García. <i>Specialist in Preventive Medicine and Public Health Data, Protection Officer of the Public Health System of Andalusia, Member of the Andalusian Biomedical Research Ethics Coordinating Committee</i>.</p><p>12:25–13:00 <b>DISCUSSION</b></p><p>13:00–13:30 <b>CLOSING CONFERENCE</b></p><p><b>“The evidence needed to approve medicines: are we witnessing a paradigm shift?”</b></p><p>Fernando de Andrés Trelles. <i>Emeritus Professor, Department of Pharmacology and Toxicology, Universidad Complutense, Madrid</i>.</p><p>13:30–14:00 <b>AWARDS AND CLOSURE CEREMONY</b></p><p>Prize for the best research work (best communication).</p><p>Sponsored by Chiesi Spain.</p><p>Prize for the best publication in a scientific journal.</p><p>Sponsored by Lilly.</p><p><b>CLOSURE OF THE CONGRESS</b></p><p>Antònia Agustí Escasany. <i>President of the Spanish Society of Clinical Pharmacology</i>.</p><p>Emilio Vargas Castrillón. <i>President of the Organizing Committee of the XXXII Congress of the Spanish Society of Clinical Pharmacology</i>.</p><p>Guillermo Prada Ramallal<i>. President of the Scientific Committee of the XXXII Congress of the Spanish Society of Clinical Pharmacology</i>.</p><p>Carmen Durán. <i>General Director of Public Health, Consejería de Sanidad Gobierno Gallego</i>.</p>","PeriodicalId":8733,"journal":{"name":"Basic & Clinical Pharmacology & Toxicology","volume":"135 S1","pages":"5-8"},"PeriodicalIF":2.7000,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/bcpt.14065","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Basic & Clinical Pharmacology & Toxicology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/bcpt.14065","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
WEDNESDAY 16 OCTOBER 2024
10:00–14:00 ANNUAL MEETING OF RESEARCH ETHICS COMMITTEES
Spanish Agency of Medicines and Medical Devices and Spanish Society of Clinical Pharmacology
15:30–18:30 PRE-CONGRESS WORKSHOPS AND SEMINARS
“Next-generation of “deep” medicine: A look from machine learning to generative AI”
Guillermo Prada Ramallal. Clinical Pharmacologist, Hospital Clínico Universitario, Santiago de Compostela.
Laura Romero Sánchez. Technical Secretary of Research Ethics Committee of Galicia, Gerencia del Servicio Gallego de Salud.
“Evaluation of the therapeutic value of medicines: controversies and future perspectives”
Arantxa Sancho López. Clinical Pharmacologist, Head of Medical-Scientific Department of Farmaindustria.
Emilio Vargas Castrillón. Professor of Pharmacology, Head of Clinical Pharmacology Department, Hospital Clínico San Carlos, Universidad Complutense, Madrid.
Pedro Zapater Hernández. Head of Section of Clinical Pharmacology Department, Hospital General Universitario Dr. Balmis, Universidad Miguel Hernández, Alicante.
Alejandro García Solís. Therapeutic Positioning Reporting Area and Health Technology Assessment, Spanish Agency of Medicines and Medical Devices.
“Medicines in special situations”
Concepción Payares Herrera. Clinical Pharmacologist, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid.
Imma Danés Carreras. Head of section of Clinical Pharmacology Department, Hospital Universitario Vall d'Hebron, Barcelona.
19:00 INAUGURATION OF THE CONGRESS
Antònia Agustí Escasany. President of the Spanish Society of Clinical Pharmacology.
Emilio Vargas Castrillón. President of the Organizing Committee of the XXXII Congress of the Spanish Society of Clinical Pharmacology.
Guillermo Prada Ramallal. President of the Scientific Committee of the XXXII Congress of the Spanish Society of Clinical Pharmacology.
Carmen Durán. General Director of Public Health, Consejería de Sanidad Gobierno Gallego.
19:30 INAUGURAL CONFERENCE
“Novelties in therapeutics: Advanced therapies and other innovations”
Cristina Avendaño Solá. Head of Clinical Pharmacology Department, Hospital Puerta de Hierro, Majadahonda, Universidad Autónoma, Madrid.
20:30 WELCOME COCKTAIL
THURSDAY 17 OCTOBER 2024
08:30–09:15 REGISTRATION
09:15–11:15 1ST ROUND TABLE
“Medicine research in Europe, pros and cons of making the medicine authorization process more flexible”
Moderators:
Ana Lucía Arellano Andrino. Clinical Pharmacologist, Hospital Clínic, Barcelona.
Emilio Vargas Castrillón. Professor of Pharmacology, Head of Clinical Pharmacology Department, Hospital Clínico San Carlos, Universidad Complutense, Madrid.
09:20–09:40 “Evolution of medicine authorization procedures in Europe”
Macarena Rodríguez Mendizábal. Division of Clinical Pharmacology and Assessment of Medicines, Spanish Agency of Medicines and Clinical Devices.
09:40–10:00 “Impact of accelerating medicine authorization processes on healthcare management”
Antoni Vallano Ferraz. Coordinator of the Drug Harmonization Program, Àrea del Medicament del Servei Català de la Salut.
10:00–10:20 “The research on medicines in Europe, pros and cons of making the drug authorization more flexible. Advantages and uncertainties in the paediatric population”
Federico Martinón Torres. Head of Paediatric Department, Hospital Clínico Universitario, Santiago de Compostela.
10:20–10:40 “The research on medicines in Europe, pros and cons of making the drug authorization more flexible. Advantages and uncertainties in the oncological patients”
Luis León Mateos. Head of Section of Research and Innovation, Clinical Oncology Department, Hospital Clínico Universitario, Santiago de Compostela.
10:40–11:15 DISCUSSION
11:15–12:00 COFFEE BREAK, POSTER SESSION AND NETWORKING
12:00–13:30 1ST SESSION OF ORAL COMMUNICATIONS
Moderators:
Encarnación Blanco Reina. Clinical Pharmacologist, Department of Pharmacology and Paediatrics, Universidad de Málaga.
Pedro Zapater Hernández. Head of Section Clinical Pharmacology Department, Hospital General Universitario Dr Balmis, Universidad Miguel Hernández, Alicante.
13:30–14:00 “Strategy for the implementation of pharmacogenetics at the healthcare level in the Community of Madrid”
Susana Almenara Riquer. Clinical Pharmacology Department, Hospital Universitario de la Princesa, Madrid.
Elena Diago Sempere. Clinical Pharmacology Department, Hospital Universitario La Paz, Madrid.
Ana Ascaso del Río. Clinical Pharmacology Department, Hospital Universitario Clínico San Carlos, Madrid.
Antonio Carcas Sansúan. Hospital Universitario La Paz, Madrid.
Alberto Borobia Pérez. Hospital Universitario La Paz, Madrid.
Cristina Avendaño Sola. Hospital Universitario Puerta de Hierro, Majadahonda, Madrid.
Francisco Abad Santos. Hospital Universitario de la Princesa, Madrid.
14:00–15:30 LUNCH
15:30–17:00 2ND ROUND TABLE
“Chronic diseases, polytherapy and health outcomes”
Moderators:
Mª Estrella Barceló Colomer. Clinical Pharmacologist, Medicine Area of Primary Care Management and Community Care in Barcelona City, Institut Català de la Salut.
Mario González Ruíz. Clinical Pharmacologist, Clinical Pharmacology Department of Primary Care, Gerencia de Atención Primaria del Servicio Cántabro de Salud.
15:35–15:55 “The epidemiology of chronicity and polypharmacy”
Arturo González Quintela. Specialist in Internal Medicine, Head of Section Internal Medicine Department, Hospital Clínico Universitario, Santiago de Compostela.
15:55–16:15 “Polypharmacy and deprescription”
Beatriz Montero Errasquín. Specialist in Geriatrics, Head of Section Geriatric Department, Hospital Universitario Ramón y Cajal, Servicio Madrileño de Salud.
16:15–16:35 “Health outcomes in chronic patients with polytherapy”
Rosendo Bugarín González. Family Doctor, Monforte de Lemos Health Center, Servicio Galego de Saúde.
16:35–17:00 DISCUSSION
17:00–17:30 COFFEE BREAK, POSTER SESSION AND NETWORKING
17:30–19:30 GENERAL ASSEMBLY OF THE SPANISH SOCIETY OF CLINICAL PHARMACOLOGY
21:00 CONGRESS DINNER
FRIDAY 18 OCTOBER 2024
09:00–10:30 2ND SESSION OF ORAL COMMUNICATIONS
Moderators:
María del Mar García Saiz. Head of Clinical Pharmacology Department, Hospital Universitario Marqués de Valdecilla, Santander.
Amelia García Luque. Head of Clinical Pharmacology Department, Hospital Central de la Defensa, Madrid.
10:30–11:00 COFFEE BREAK, POSTER SESSION AND NETWORKING
11:00–13:00 3RD ROUND TABLE
“Artificial intelligence in Medicine: technology, research, education and ethics”
Moderators:
Emilio Vargas Castrillón. Professor of Pharmacology, Head of Clinical Pharmacology Department, Hospital Clínico San Carlos, Universidad Complutense, Madrid.
Guillermo Prada Ramallal. Clinical Pharmacologist, Hospital Clínico Universitario, Santiago de Compostela.
11:05–11:25 “Generative AI in Medicine”
Senén Barro Ameneiro. Director of the USC-Plexus of AI in personalized precision medicine and director of the unique research center in intelligent technologies, Universidad de Santiago de Compostela.
11:25–11:45 “Use of artificial intelligence in pharmacoepidemiological research: Experience and application perspectives in BIFAP”
Miguel Ángel Maciá Martínez. Coordinator of the Pharmacoepidemiologic Research in Public Health Systems Database, Head of the Pharmacoepidemiology Area, Pharmacoepidemiology and Pharmacovigilance Division, Spanish Agency of Medicines and Medical Devices.
11:45–12:05 “Challenges for the widespread implementation of AI in healthcare”
Maria José Carreira Nouche. Unique Research Center in Intelligent Technologies, Universidad de Santiago de Compostela, Fundación Instituto de Investigación Sanitaria de Santiago de Compostela.
12:05–12:25 “Reliable AI in Medicine: Regulation and Ethics”
Juan Díaz García. Specialist in Preventive Medicine and Public Health Data, Protection Officer of the Public Health System of Andalusia, Member of the Andalusian Biomedical Research Ethics Coordinating Committee.
12:25–13:00 DISCUSSION
13:00–13:30 CLOSING CONFERENCE
“The evidence needed to approve medicines: are we witnessing a paradigm shift?”
Fernando de Andrés Trelles. Emeritus Professor, Department of Pharmacology and Toxicology, Universidad Complutense, Madrid.
13:30–14:00 AWARDS AND CLOSURE CEREMONY
Prize for the best research work (best communication).
Sponsored by Chiesi Spain.
Prize for the best publication in a scientific journal.
Sponsored by Lilly.
CLOSURE OF THE CONGRESS
Antònia Agustí Escasany. President of the Spanish Society of Clinical Pharmacology.
Emilio Vargas Castrillón. President of the Organizing Committee of the XXXII Congress of the Spanish Society of Clinical Pharmacology.
Guillermo Prada Ramallal. President of the Scientific Committee of the XXXII Congress of the Spanish Society of Clinical Pharmacology.
Carmen Durán. General Director of Public Health, Consejería de Sanidad Gobierno Gallego.
期刊介绍：
Basic & Clinical Pharmacology and Toxicology is an independent journal, publishing original scientific research in all fields of toxicology, basic and clinical pharmacology. This includes experimental animal pharmacology and toxicology and molecular (-genetic), biochemical and cellular pharmacology and toxicology. It also includes all aspects of clinical pharmacology: pharmacokinetics, pharmacodynamics, therapeutic drug monitoring, drug/drug interactions, pharmacogenetics/-genomics, pharmacoepidemiology, pharmacovigilance, pharmacoeconomics, randomized controlled clinical trials and rational pharmacotherapy. For all compounds used in the studies, the chemical constitution and composition should be known, also for natural compounds.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
